For this reason, Gross et al. [137] conducted a study using recombinant AAV serotype-2-neurturin (AAV2-NRTN) to evaluate its safety, tolerability and efficacy in the SOD1-G93A ALS mice model. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.